Global Veterinary Drug Market Growth 2025-2031
Description
The global Veterinary Drug market size is predicted to grow from US$ 27080 million in 2025 to US$ 37780 million in 2031; it is expected to grow at a CAGR of 5.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The growth of the veterinary drug market is primarily driven by the rising global demand for animal protein, such as meat, milk, and eggs, which necessitates improved animal health and productivity. Increasing pet ownership and heightened awareness of animal welfare are also contributing to greater demand for preventive and therapeutic veterinary treatments. Moreover, advancements in veterinary medicine—such as targeted antibiotics, vaccines, and parasiticides—are helping to address a wide range of animal diseases more effectively. Government initiatives and regulatory support for animal healthcare further strengthen the market, especially in emerging economies with expanding livestock and pet populations.
A major challenge in the veterinary drug market is the growing concern over antimicrobial resistance (AMR) resulting from the overuse and misuse of antibiotics in animals. Regulatory authorities are imposing stricter rules on drug approvals and usage, which can increase development costs and limit market accessibility for certain products. Additionally, the high cost and lengthy process of veterinary drug development—combined with the need for specialized R&D infrastructure—pose significant barriers to entry for smaller firms. Price sensitivity in developing regions and limited access to veterinary care in rural areas also hinder market penetration, particularly for premium or innovative drug formulations.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Drug Industry Forecast” looks at past sales and reviews total world Veterinary Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Drug sales for 2025 through 2031. With Veterinary Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Drug industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segmentation by Application:
Pets
Cattle
Poultry
Swine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur
Jinhe Bio
Qianjiang Biochemical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Drug market?
What factors are driving Veterinary Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Drug market opportunities vary by end market size?
How does Veterinary Drug break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The growth of the veterinary drug market is primarily driven by the rising global demand for animal protein, such as meat, milk, and eggs, which necessitates improved animal health and productivity. Increasing pet ownership and heightened awareness of animal welfare are also contributing to greater demand for preventive and therapeutic veterinary treatments. Moreover, advancements in veterinary medicine—such as targeted antibiotics, vaccines, and parasiticides—are helping to address a wide range of animal diseases more effectively. Government initiatives and regulatory support for animal healthcare further strengthen the market, especially in emerging economies with expanding livestock and pet populations.
A major challenge in the veterinary drug market is the growing concern over antimicrobial resistance (AMR) resulting from the overuse and misuse of antibiotics in animals. Regulatory authorities are imposing stricter rules on drug approvals and usage, which can increase development costs and limit market accessibility for certain products. Additionally, the high cost and lengthy process of veterinary drug development—combined with the need for specialized R&D infrastructure—pose significant barriers to entry for smaller firms. Price sensitivity in developing regions and limited access to veterinary care in rural areas also hinder market penetration, particularly for premium or innovative drug formulations.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Drug Industry Forecast” looks at past sales and reviews total world Veterinary Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Drug sales for 2025 through 2031. With Veterinary Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Drug industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segmentation by Application:
Pets
Cattle
Poultry
Swine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur
Jinhe Bio
Qianjiang Biochemical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Drug market?
What factors are driving Veterinary Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Drug market opportunities vary by end market size?
How does Veterinary Drug break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
133 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Veterinary Drug by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Veterinary Drug by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
